Your Followed Topics

0.00%
health1d ago

www.wiltsglosstandard.co.uk
Open in Wiltsglosstandard.co.uk
Highlights
  • A two-pronged treatment targeting AR signaling and cancer energetics could benefit up to 40 percent of those with late-stage prostate cancer.
  • The strategy uses existing or in-development drugs to slow tumor growth and induce cancer cell death by disabling proteins that help cancer cells survive.
  • Combining an MCL1-seeking approach with AKT suppression yields enhanced prostate cancer cell death in lab models and slows tumor growth in mice.

Virality Score Timeline

Vote 13
0

References

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Double-pronged attack on advanced prostate cancer shows promise

Docs find new vulnerability that may mean better prostate cancer treatment

Docs find new vulnerability that may mean better prostate cancer treatment

Scientists identify drug combination that can weaken prostate cancer cells

Scientists identify drug combination that can weaken prostate cancer cells

Related Topics

0 Comments

Be the first to comment

Add your thoughts and get the conversation going.

Top 890 Internet News Today

Explore Your Interests

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access
Personalized Feed
Full Experience
By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.